Mohsen Farvardin1, Abdulrahim Amini2, Younes Azizpourfard1, Masoud Yasemi1, Zahra Mahdizad3, Mohammadkarim Johari4. 1. Poostchi Ophthalmology Research Center, Department of Ophthalmology, School of Medicine, Shiraz University of Medical Sciences, Zand Street, Shiraz, Iran. 2. Department of ophthalmology, school of medicine, Hormozgan University of medical sciences, Bandar Abbas, Iran. 3. Eye Research Center, Farabi Eye Hospital, Tehran University of medical science, Tehran, Iran. 4. Poostchi Ophthalmology Research Center, Department of Ophthalmology, School of Medicine, Shiraz University of Medical Sciences, Zand Street, Shiraz, Iran. mkjoharii@gmail.com.
Abstract
PURPOSE: to determine the percentage of patients with pachychoroid neovasculopathy (PNV) among patients who have been misdiagnosed and treated with wet age-related macular degeneration (AMD). METHODS: In this retrospective cross-sectional study, patients over 55 years old, who were diagnosed with wet AMD, were re-evaluated. All patients were recalled for examination and imaging. Patients with PNV were differentiated form wet AMD based on inclusion and exclusion criteria. RESULTS: Overall, 120 patients (137 eyes) were recorded with wet AMD in the clinic. Finally, after complete re-evaluation, 94 (106 eyes) and 26 patients (31 eyes) were assigned to the AMD and the PNV group, respectively. Thus, a total of 20% of patients with primary mistake diagnosis of wet AMD, actually had PNV. The mean sub field choroidal thickness (SFCT) in the AMD and PNV groups was 173.8 ± 69 μm and 342 ± 27 μm, respectively. Drusen and pachydrusen were found in 69.9% and 24% of the cases with AMD and PNV, respectively (P = 0.001). The average number of intravitreal injections of anti-VEGF (vascular endothelial growth factor) required in the AMD and PNV groups was about 5 and 3, respectively, which was statistically significant (P-value 0.02). CONCLUSION: This study revealed that about a one-fifth of wet AMD patients are actually pachychoroid neovasculopathy. These patients were younger and had thicker SFCT, and developed less subretinal scarring. Thus, the disorder must be considered as an important differential diagnosis of AMD-CNV.
PURPOSE: to determine the percentage of patients with pachychoroid neovasculopathy (PNV) among patients who have been misdiagnosed and treated with wet age-related macular degeneration (AMD). METHODS: In this retrospective cross-sectional study, patients over 55 years old, who were diagnosed with wet AMD, were re-evaluated. All patients were recalled for examination and imaging. Patients with PNV were differentiated form wet AMD based on inclusion and exclusion criteria. RESULTS: Overall, 120 patients (137 eyes) were recorded with wet AMD in the clinic. Finally, after complete re-evaluation, 94 (106 eyes) and 26 patients (31 eyes) were assigned to the AMD and the PNV group, respectively. Thus, a total of 20% of patients with primary mistake diagnosis of wet AMD, actually had PNV. The mean sub field choroidal thickness (SFCT) in the AMD and PNV groups was 173.8 ± 69 μm and 342 ± 27 μm, respectively. Drusen and pachydrusen were found in 69.9% and 24% of the cases with AMD and PNV, respectively (P = 0.001). The average number of intravitreal injections of anti-VEGF (vascular endothelial growth factor) required in the AMD and PNV groups was about 5 and 3, respectively, which was statistically significant (P-value 0.02). CONCLUSION: This study revealed that about a one-fifth of wet AMD patients are actually pachychoroid neovasculopathy. These patients were younger and had thicker SFCT, and developed less subretinal scarring. Thus, the disorder must be considered as an important differential diagnosis of AMD-CNV.
Authors: L A Yannuzzi; D W Wong; B S Sforzolini; M Goldbaum; K C Tang; R F Spaide; K B Freund; J S Slakter; D R Guyer; J A Sorenson; Y Fisher; D Maberley; D A Orlock Journal: Arch Ophthalmol Date: 1999-11
Authors: Daniela Ferrara; Kathrin J Mohler; Nadia Waheed; Mehreen Adhi; Jonathan J Liu; Ireneusz Grulkowski; Martin F Kraus; Caroline Baumal; Joachim Hornegger; James G Fujimoto; Jay S Duker Journal: Ophthalmology Date: 2013-11-26 Impact factor: 12.079
Authors: Chui M Gemmy Cheung; Timothy Y Y Lai; Kelvin Teo; Paisan Ruamviboonsuk; Shih-Jen Chen; Judy E Kim; Fumi Gomi; Adrian H Koh; Gregg Kokame; Janice Marie Jordan-Yu; Federico Corvi; Alessandro Invernizzi; Yuichiro Ogura; Colin Tan; Paul Mitchell; Vishali Gupta; Jay Chhablani; Usha Chakravarthy; Srinivas R Sadda; Tien Y Wong; Giovanni Staurenghi; Won Ki Lee Journal: Ophthalmology Date: 2020-08-11 Impact factor: 12.079